Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 February 2018 Photo Esti Strydom
Not a laughing stock Phil de Lange
Phil de Lange

Phil de Lange studied for a BA Integrated Marketing Communication and English + TEFL at the University of the Free State (UFS) from 2008-2011. During that time, he was a Kovsie FM presenter, which paved the way for his blossoming career in radio. Currently, Phil is the producer of the Smile Breakfast show on Smile 90.4FM, and is a co-host of Sunday Night Comedy Hour at the same station. He also performs as a comedian.

“My biggest career obstacle was to balance the expensive realities of life while trying to get a foot in the door of the career I wanted,” said Phil.

“The best career advice I can currently give is to read, research, study future trends, and be prepared. Know who to listen to, and who to ignore. Also, you are more important than any company. Look after your physical, emotional and mental well-being. Unfortunately, most companies don’t really have that in mind.  

“My fondest memories of the UFS are having fun with the Kovsie FM team, intense class discussions with Dr Brooks and Ms Lovisa from the English Department, and chilling by the fountains in front of the main building. Not to mention passing a re-write with distinction from a hospital bed. I wasn’t hospitalised due to the re-write, it just happened at the same time!

“The best thing about being a comedian is the platform you get – it’s like nothing else. Having people listen to you intently for a long time and laughing at your jokes is exhilarating. And the worst thing is realising that not everything you think is funny, is funny.

“I have an appreciation for radio that few other people have. I love it. I love how it’s still so important to millions of people. I am also privileged to be working with some of the best and most passionate people in South African radio.” 

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept